Relapsed/Refractory Aggressive B-cell Lymphomas
Also known as: Relapsed/Refractory Aggressive B-Cell Lymphoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB14707 | Cemiplimab | 1 | Recruiting | 1 |
| DB16684 | Odronextamab | 1 | Recruiting | 1 |
| DB12530 | Inebilizumab | 1 / 2 | Completed | 1 |
| DB15768 | MEDI0680 | 1 / 2 | Completed | 1 |